| [a trial treatment with eflornithine of trypanosomiasis caused by trypanosoma brucei gambiense in the peoples republic of the congo]. | in a multiclinic trial in brazzaville, congo, 14 patients with late-stage trypanosoma brucei gambiense trypanosomiasis were treated with eflornithine. all cases had previously been treated with one or several courses of melarsoprol. eflornithine treatment consisted of 400 mg/kg/day intravenously for 14 days followed by 300 mg/kg/day orally for 21 days. after treatment all patients had a disappearance of trypanosomes from cerebrospinal fluid (csf), a normalization of csf wbc count, and, where pre ... | 1989 | 2507863 |